Stay updated on Psilocybin Safety & Efficacy in BP-II Depression Clinical Trial
Sign up to get notified when there's something new on the Psilocybin Safety & Efficacy in BP-II Depression Clinical Trial page.

Latest updates to the Psilocybin Safety & Efficacy in BP-II Depression Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe site footer now identifies the platform as revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check22 days agoChange DetectedA notice about NIH website changes and the transition from “Artificial Intelligence” to “Super Intelligence” appears above the study record.SummaryDifference0.8%

- Check29 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check36 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1, with no change to the study record content.SummaryDifference0.1%

- Check57 days agoChange DetectedA new revision entry v3.7.0 was added to the study record history, updating the version reference from v3.6.6. This reflects an administrative update to the record's documentation and does not modify study data or public-facing content.SummaryDifference0.1%

- Check78 days agoChange DetectedThe record history adds a new revision entry labeled v3.6.6 and notes the removal of v3.6.5. This reflects an update to the page's revision history.SummaryDifference0.1%

Stay in the know with updates to Psilocybin Safety & Efficacy in BP-II Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin Safety & Efficacy in BP-II Depression Clinical Trial page.